Scarica l'app Stockscreener
111.70
1.38%
-1.56
Dopo l'orario di chiusura:
111.70
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$113.26
Aprire:
$112.3
Volume 24 ore:
1.41M
Relative Volume:
0.64
Capitalizzazione di mercato:
$31.57B
Reddito:
$7.07B
Utile/perdita netta:
$1.29B
Rapporto P/E:
24.63
EPS:
4.5355
Flusso di cassa netto:
$993.00M
1 W Prestazione:
-3.39%
1M Prestazione:
-6.74%
6M Prestazione:
-23.92%
1 anno Prestazione:
-0.62%
Intervallo 1D:
$111.44
$113.08
Intervallo di 1 settimana:
$111.09
$115.85
Portata 52W:
$107.07
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
111.70 | 32.01B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
438.34 | 166.56B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
161.91 | 116.46B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
528.79 | 42.03B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
329.22 | 32.72B | 3.77B | 449.25M | 240.68M | 7.8556 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
TRADE NEWS: Agilent Technologies Introduces Industry's First LTE-Advanced 8x8 MIMO Signal-Generation - AOL.com
Agilent $40M Expansion Doubles Chicopee Manufacturing Site - Hoodline
Agilent Technologies opens new Chicopee manufacturing facility - The Reminder
Agilent invests $40M to double Massachusetts manufacturing site - The Business Journals
What Makes Agilent (A) a New Buy Stock - Yahoo Finance
Agilent Technologies Inc. stock (US00846U1016): Q1 2026 earnings miss by a cent as guidance points t - AD HOC NEWS
Agilent Technologies Inc. stock (US00846U1016): Q1 2026 earnings miss by a hair while revenue rises - AD HOC NEWS
Global company Agilent Technologies opens new Chicopee site - WWLP
Agilent Technologies stock (US00846U1016): Recent patent ruling and market updates - AD HOC NEWS
Agilent & Veeda Lifesciences Strengthen Biopharma Analytics with New Facility - Digital Health News
Enablement For Validity Versus Enablement For Anticipation: Lessons From Agilent Technologies, Inc. v. Synthego Corp. - marketscreener.com
Agilent Technologies (A) Valuation Check As New Biopharma Collaborations And Logic Analyzers Expand Growth Story - simplywall.st
Agilent and Veeda Lifesciences open joint analytical Centre of Excellence in Bengaluru - BioSpectrum India
Agilent Technologies Inc. stock (US00846U1016): Short interest rises amid market pressures - AD HOC NEWS
Agilent And Veeda Lifesciences Launch Joint Analytical Center Of Excellence To Accelerate GLP‑1 And Complex Biologics Development Services. - TRIPURA STAR NEWS
Agilent and Veeda Lifesciences Launch Joint Analytical CoE to Accelerate GLP‑1 and Complex Biologics Development Services - Indianweb2.com
Agilent Technologies or Danaher: Which Stock Has More Upside? - Trefis
Agilent Tech Q2 Net Drops, Job Cuts and Share Repurchase Widening Announced - AOL.com
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent (A) SVP Simon May surrenders 368 shares to cover RSU tax bill - Stock Titan
Here's what to expect from Agilent Technologies’ next earnings report - MSN
C-CAMP announces expansion of tie-up with Agilent - The Hindu
TRADE NEWS: Agilent Technologies Introduces New Portable Logic Analyzers - AOL.com
Agilent and C‑CAMP Expand Collaboration to Boost India’s Biopharma Research Infrastructure - Indianweb2.com
Agilent expands collaboration with C-CAMP to scale access to advanced life sciences analytics - BioSpectrum India
Agilent to Participate in Jefferies Global Healthcare Conference 2026 - BioSpace
Agilent to Participate in Jefferies Global Healthcare Conference - The National Law Review
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent Technologies stock (US00846U1016): Q1 earnings miss and upcoming Q2 report - AD HOC NEWS
Agilent Technologies stock (US00846U1016): Q1 earnings miss and updated guidance - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a Potential 38.98% Upside for Savvy Investors - DirectorsTalk Interviews
Crossmark Global Holdings Inc. Acquires 9,615 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Taps Cirena To Turn Long RNA Technology Into Genome Editing Growth - Yahoo Finance
Is Agilent Technologies (A) Fairly Priced After Mixed Returns And DCF Upside Signals? - simplywall.st
FDA approves Agilent PD-L1 test for esophageal cancer - SelectScience
Agilent Technologies Inc. stock (US00846U1016): FDA approval and earnings miss shape outlook - AD HOC NEWS
Generali Asset Management SPA SGR Has $7.38 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
TRADE NEWS: Agilent Technologies' Model Extraction and Qualification Software Adopted by Shanghai Co - Yahoo
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
[Form 3] AGILENT TECHNOLOGIES, INC. Initial Statement of Beneficial Ownership - Stock Titan
AAgilent Technologies Inc Stock Price and Quote - Finviz
Cirena licenses Agilent long RNA purification technology for high-purity genome editing workflows - Manufacturing Chemist
Dna Forensic Market Is Booming So Rapidly | Agilent Technologies, Illumina, Bio-Rad Laboratories - openPR.com
Swedbank AB Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing - Indian Pharma Post
Robeco Schweiz AG Has $142.75 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Taps Danaher Deal Lawyer As Chief Legal Officer - Law360
Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight - GlobeNewswire Inc.
A Stock Price Prediction 2025-2026 | Agilent Technologies Inc Forecast | 24/7 Wall St. - 24/7 Wall St.
Assessing Agilent Technologies (A) Valuation After FDA Approval Of PD L1 Assay For KEYTRUDA - Yahoo Finance
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):